Qvar Redihaler Aerosol, Metered
NDC Package 59310-302-40

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Qvar Redihaler (beclomethasone dipropionate hfa) aerosols is beclomethasone is used to prevent and control symptoms (wheezing and shortness of breath) caused by asthma. This formulation utilizes a aerosol, metered delivery system. Marketed by Teva Respiratory, Llc, this product is identified by NDC 59310-302 and is authorized under FDA application NDA207921.

Identification & Billing

NDC Package Code
59310-302-40
Package Description
1 INHALER in 1 CARTON / 1 CANISTER in 1 INHALER / 120 AEROSOL, METERED in 1 CANISTER
Product Code
11-Digit Billing Format
59310030240
Billing Unit
GM - Billing unit of "gram" is used when a product is measured by its weight.
RxNorm Crosswalk
  • RxCUI: 1998771 - beclomethasone dipropionate 80 MCG/ACTUAT Breath-Actuated Metered Dose Inhaler, 120 ACTUAT
  • RxCUI: 1998771 - Breath-Actuated 120 ACTUAT beclomethasone dipropionate 0.08 MG/ACTUAT Metered Dose Inhaler
  • RxCUI: 1998772 - QVAR Redihaler 80 MCG/ACTUAT Breath-Actuated Metered Dose Inhaler, 120 ACTUAT
  • RxCUI: 1998772 - Breath-Actuated 120 ACTUAT beclomethasone dipropionate 0.08 MG/ACTUAT Metered Dose Inhaler [Qvar]
  • RxCUI: 1998772 - Breath-Actuated 120 ACTUAT Qvar 0.08 MG/ACTUAT Metered Dose Inhaler

Clinical Specifications

Proprietary Name
Qvar Redihaler
Non-Proprietary Name
Beclomethasone Dipropionate Hfa
Substance Name
Beclomethasone Dipropionate
Dosage Form
Aerosol, Metered - A pressurized dosage form consisting of metered dose valves which allow for the delivery of a uniform quantity of spray upon each activation.
Administration Route
Respiratory (inhalation) - Administration within the respiratory tract by inhaling orally or nasally for local or systemic effect.
Usage Information
Beclomethasone is used to prevent and control symptoms (wheezing and shortness of breath) caused by asthma. This medication belongs to a class of drugs known as corticosteroids. It works by reducing the swelling of the airways in the lungs to make breathing easier. This medication must be used regularly to prevent breathing problems (attacks of wheezing/shortness of breath). It does not work right away and should not be used to relieve an asthma attack. If an attack occurs, use your quick-relief inhaler as prescribed.

Regulatory & Marketing

Labeler Name
Teva Respiratory, Llc
Product Type
Human Prescription Drug
FDA Application #
NDA207921
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
02-15-2018
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (59310-302). Click a package code to view its specific billing and regulatory data.

1 INHALER in 1 CARTON / 1 CANISTER in 1 INHALER / 120 AEROSOL, METERED in 1 CANISTER

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 59310-302-40 identifies a specific commercial package of 1 inhaler in 1 carton / 1 canister in 1 inhaler / 120 aerosol, metered in 1 canister of Qvar Redihaler, a human prescription drug labeled by Teva Respiratory, Llc. This aerosol, metered is formulated for respiratory (inhalation) use and contains beclomethasone dipropionate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Teva Respiratory, Llc on February 15, 2018. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Beclomethasone is used to prevent and control symptoms (wheezing and shortness of breath) caused by asthma. This medication belongs to a class of drugs known as corticosteroids. It works by reducing the swelling of the airways in the lungs to make breathing easier. This medication must be used regularly to prevent breathing problems (attacks of wheezing/shortness of breath). It does not work right away and should not be used to relieve an asthma attack. If an attack occurs, use your quick-relief inhaler as prescribed.

How is this Teva Respiratory, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 59310030240. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
59310-302-40
11-Digit CMS (5-4-2)
59310-0302-40

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.